Special issue: adenosine receptors

Publication date

2018-05-02T09:25:39Z

2018-05-02T09:25:39Z

2017-07-20

2018-05-02T09:25:39Z

Abstract

Nearly 90 years ago, Drury and Szent-Györgyi revealed that adenosine produced profound hypotension and bradycardia, and it affected kidney function in mammals [1]. Since then, the physiological role and potential therapeutic use of adenosine have been extensively explored [2,3]. Adenosine is considered a retaliatory metabolite [4], thus increasing oxygen supply and decreasing oxygen consumption.

Document Type

Article


Published version

Language

English

Publisher

MDPI

Related items

Reproducció del document publicat a: https://doi.org/10.3390/molecules22071220

Molecules, 2017, vol. 22, num. 7, p. 1220

https://doi.org/10.3390/molecules22071220

Recommended citation

This citation was generated automatically.

Rights

cc-by (c) Ciruela Alférez, Francisco et al., 2017

http://creativecommons.org/licenses/by/3.0/es